Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan G E Wilson

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 25, 2024
Xenobiotica Special Edition PrefaceAlan G E Wilson
Future Medicinal Chemistry|March 24, 2011
The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and developmentXiang-Qing Yu, Alan G E Wilson
Future Medicinal Chemistry|March 24, 2011
Development and application of a high-throughput formulation screening strategy for oral administration in drug discoverySuma Gopinathan, Amr Nouraldeen, Alan G E Wilson
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 30, 2012
Evaluation of transporter-mediated hepatic uptake in a non-radioactive high-throughput assay: a study of kinetics, species difference and plasma protein effectLing Li, Amr Nouraldeen, Alan G E Wilson
Future Medicinal Chemistry|March 24, 2011
A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientistAlan G E Wilson, Amr Nouraldeen, Suma Gopinathan
Future Medicinal Chemistry|March 24, 2011
Application of emerging toxicity screens in drug discovery: challenges and implicationsAlan G E Wilson, Xuemei Liu, Jeffrey A Kramer
Current Opinion in Drug Discovery & Development|March 5, 2003
Role of predictive metabolism and toxicity modeling in drug discovery--a summary of some recent advancementsAlan G E Wilson, Anita C White, Richard A Mueller
Mutation Research|September 2, 2003
A multiple in silico program approach for the prediction of mutagenicity from chemical structureAnita C White, Richard A Mueller, Robert H Gallavan, et al.
Mutation Research|May 20, 2008
Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxinsXuemei Liu, Jeffrey A Kramer, Jonathan C Swaffield, et al.
International Journal of Toxicology|June 24, 2009
Development of a high-throughput human HepG(2) dual luciferase assay for detection of metabolically activated hepatotoxicants and genotoxicantsXuemei Liu, Jeffrey A Kramer, Yi Hu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 25, 2024
Xenobiotica Special Edition PrefaceAlan G E Wilson
Future Medicinal Chemistry|March 24, 2011
The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and developmentXiang-Qing Yu, Alan G E Wilson
Future Medicinal Chemistry|March 24, 2011
Development and application of a high-throughput formulation screening strategy for oral administration in drug discoverySuma Gopinathan, Amr Nouraldeen, Alan G E Wilson
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 30, 2012
Evaluation of transporter-mediated hepatic uptake in a non-radioactive high-throughput assay: a study of kinetics, species difference and plasma protein effectLing Li, Amr Nouraldeen, Alan G E Wilson
Future Medicinal Chemistry|March 24, 2011
A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientistAlan G E Wilson, Amr Nouraldeen, Suma Gopinathan
Future Medicinal Chemistry|March 24, 2011
Application of emerging toxicity screens in drug discovery: challenges and implicationsAlan G E Wilson, Xuemei Liu, Jeffrey A Kramer
Current Opinion in Drug Discovery & Development|March 5, 2003
Role of predictive metabolism and toxicity modeling in drug discovery--a summary of some recent advancementsAlan G E Wilson, Anita C White, Richard A Mueller
Mutation Research|September 2, 2003
A multiple in silico program approach for the prediction of mutagenicity from chemical structureAnita C White, Richard A Mueller, Robert H Gallavan, et al.
Mutation Research|May 20, 2008
Development of a highthroughput yeast-based assay for detection of metabolically activated genotoxinsXuemei Liu, Jeffrey A Kramer, Jonathan C Swaffield, et al.
International Journal of Toxicology|June 24, 2009
Development of a high-throughput human HepG(2) dual luciferase assay for detection of metabolically activated hepatotoxicants and genotoxicantsXuemei Liu, Jeffrey A Kramer, Yi Hu, et al.
Pageof 3